• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RAGE 轴:对脆弱血管发出危险信号的基本机制。

The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.

机构信息

Division of Surgical Science, Department of Surgery, Columbia University, 630 W 168th St, P&S 17-401, New York, NY 10032, USA.

出版信息

Circ Res. 2010 Mar 19;106(5):842-53. doi: 10.1161/CIRCRESAHA.109.212217.

DOI:10.1161/CIRCRESAHA.109.212217
PMID:20299674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2862596/
Abstract

The immunoglobulin superfamily molecule RAGE (receptor for advanced glycation end product) transduces the effects of multiple ligands, including AGEs (advanced glycation end products), advanced oxidation protein products, S100/calgranulins, high-mobility group box-1, amyloid-beta peptide, and beta-sheet fibrils. In diabetes, hyperglycemia likely stimulates the initial burst of production of ligands that interact with RAGE and activate signaling mechanisms. Consequently, increased generation of proinflammatory and prothrombotic molecules and reactive oxygen species trigger further cycles of oxidative stress via RAGE, thus setting the stage for augmented damage to diabetic tissues in the face of further insults. Many of the ligand families of RAGE have been identified in atherosclerotic plaques and in the infarcted heart. Together with increased expression of RAGE in diabetic settings, we propose that release and accumulation of RAGE ligands contribute to exaggerated cellular damage. Stopping the vicious cycle of AGE-RAGE and RAGE axis signaling in the vulnerable heart and great vessels may be essential in controlling and preventing the consequences of diabetes.

摘要

免疫球蛋白超家族分子 RAGE(晚期糖基化终产物受体)转导多种配体的作用,包括 AGEs(晚期糖基化终产物)、高级氧化蛋白产物、S100/钙粒蛋白、高迁移率族盒-1、β-淀粉样肽和β-片层纤维。在糖尿病中,高血糖可能会刺激与 RAGE 相互作用并激活信号转导机制的配体的初始爆发。因此,促炎和促血栓形成分子以及活性氧的增加生成通过 RAGE 引发进一步的氧化应激循环,从而为面对进一步的损伤时糖尿病组织的增强损伤奠定基础。RAGE 的许多配体家族已在动脉粥样硬化斑块和梗死的心脏中被识别。与糖尿病环境中 RAGE 表达增加一起,我们提出 RAGE 配体的释放和积累有助于细胞损伤的加剧。在易受影响的心脏和大血管中停止 AGE-RAGE 和 RAGE 轴信号的恶性循环可能对于控制和预防糖尿病的后果至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aac1/2862596/14f176eae2f3/nihms190176f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aac1/2862596/14f176eae2f3/nihms190176f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aac1/2862596/14f176eae2f3/nihms190176f1.jpg

相似文献

1
The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature.RAGE 轴:对脆弱血管发出危险信号的基本机制。
Circ Res. 2010 Mar 19;106(5):842-53. doi: 10.1161/CIRCRESAHA.109.212217.
2
Receptor for AGE (RAGE): signaling mechanisms in the pathogenesis of diabetes and its complications.晚期糖基化终末产物受体(RAGE):糖尿病及其并发症发病机制中的信号转导机制。
Ann N Y Acad Sci. 2011 Dec;1243:88-102. doi: 10.1111/j.1749-6632.2011.06320.x.
3
The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond.晚期糖基化终产物受体轴与内皮功能障碍:在糖尿病血管及其他方面的不良作用
Trends Cardiovasc Med. 2005 Oct;15(7):237-43. doi: 10.1016/j.tcm.2005.08.003.
4
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.晚期糖基化终末产物受体(RAGE)与糖尿病并发症
Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9.
5
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.晚期糖基化终末产物受体的激活:糖尿病血管病变和动脉粥样硬化中慢性血管功能障碍的一种机制。
Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489.
6
Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response.晚期糖基化终末产物受体(RAGE)及其配体——在糖尿病和炎症反应中扮演主要角色。
J Mol Med (Berl). 2009 Mar;87(3):235-47. doi: 10.1007/s00109-009-0439-2. Epub 2009 Feb 3.
7
Periodontal disease and the oral-systemic connection: "is it all the RAGE?".牙周病与口腔-全身联系:“这一切都很热门吗?”
Quintessence Int. 2010 Mar;41(3):229-37.
8
The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease.晚期糖基化终末产物受体(RAGE)与心血管疾病
Expert Rev Mol Med. 2009 Mar 12;11:e9. doi: 10.1017/S146239940900101X.
9
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.糖基化、炎症与晚期糖基化终末产物受体:糖尿病及其他疾病大血管并发症的一个框架
Circ Res. 2003 Dec 12;93(12):1159-69. doi: 10.1161/01.RES.0000103862.26506.3D.
10
Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.晚期糖基化终末产物受体阻断:糖尿病并发症和炎症性疾病治疗干预的新靶点。
Arch Biochem Biophys. 2003 Nov 1;419(1):80-8. doi: 10.1016/j.abb.2003.08.030.

引用本文的文献

1
Treatment of Dyslipidemia in Patients with Type 1 Diabetes Mellitus: A Review of Current Evidence and Knowledge Gaps.1型糖尿病患者血脂异常的治疗:当前证据及知识空白综述
Int J Mol Sci. 2025 Sep 3;26(17):8558. doi: 10.3390/ijms26178558.
2
Identifying and establishing the critical elements of a human cardiac in-vitro model for studying type-II diabetes.识别并确立用于研究II型糖尿病的人体心脏体外模型的关键要素。
Discov Appl Sci. 2025;7(7):788. doi: 10.1007/s42452-025-07442-y. Epub 2025 Jul 15.
3
Association between metabolic health indicators and cardiorespiratory fitness in urban young and middle-aged population: a retrospective cross-sectional study.

本文引用的文献

1
Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products.罗格列酮通过上调 Akt/eNOS 通路减轻晚期糖基化终产物诱导的内皮祖细胞功能障碍。
Br J Pharmacol. 2009 Dec;158(8):1865-73. doi: 10.1111/j.1476-5381.2009.00450.x.
2
Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.晚期糖基化终产物受体在小鼠大肠杆菌诱导的腹部脓毒症中促进宿主防御。
J Infect Dis. 2009 Sep 1;200(5):765-73. doi: 10.1086/604730.
3
Receptor for advanced glycation end products is detrimental during influenza A virus pneumonia.
城市中青年人群代谢健康指标与心肺适能的关联:一项回顾性横断面研究
Front Endocrinol (Lausanne). 2025 May 21;16:1489152. doi: 10.3389/fendo.2025.1489152. eCollection 2025.
4
Exercise Empowerment: A Multifaceted Anatomy in Managing Diabetic Myocardial Disorder.运动赋能:管理糖尿病性心肌病的多维度剖析
J Cardiovasc Transl Res. 2025 Jun 4. doi: 10.1007/s12265-025-10630-1.
5
Association between neutrophil-lymphocyte ratio and all-cause and cardiovascular mortality in patients with diabetes or prediabetes with comorbid obstructive sleep apnea symptoms: evidence from NHANES 2005-2008 and 2015-2018.合并阻塞性睡眠呼吸暂停症状的糖尿病或糖尿病前期患者中性粒细胞与淋巴细胞比值与全因死亡率和心血管死亡率之间的关联:来自2005 - 2008年和2015 - 2018年美国国家健康与营养检查调查(NHANES)的证据
Front Endocrinol (Lausanne). 2025 Apr 22;16:1512621. doi: 10.3389/fendo.2025.1512621. eCollection 2025.
6
Advanced Glycation End Products in Disease Development and Potential Interventions.疾病发展中的晚期糖基化终末产物及潜在干预措施。
Antioxidants (Basel). 2025 Apr 18;14(4):492. doi: 10.3390/antiox14040492.
7
Surrogate markers of insulin resistance and coronary artery disease in type 2 diabetes: U-shaped TyG association and insights from machine learning integration.2型糖尿病中胰岛素抵抗和冠状动脉疾病的替代标志物:U型甘油三酯与葡萄糖乘积关联及机器学习整合的见解
Lipids Health Dis. 2025 Mar 15;24(1):96. doi: 10.1186/s12944-025-02526-5.
8
Serum Pentosidine in Relation to Obesity in Patients with Type 2 Diabetes and Healthy Controls.2型糖尿病患者及健康对照者血清戊糖苷与肥胖的关系
Calcif Tissue Int. 2025 Jan 7;116(1):25. doi: 10.1007/s00223-024-01338-6.
9
A Novel RAGE Modulator Induces Soluble RAGE to Reduce BACE1 Expression in Alzheimer's Disease.一种新型晚期糖基化终末产物受体调节剂可诱导可溶性晚期糖基化终末产物受体以降低阿尔茨海默病中β-分泌酶1的表达。
Adv Sci (Weinh). 2025 Feb;12(8):e2407812. doi: 10.1002/advs.202407812. Epub 2025 Jan 4.
10
Anti-hypertensive effect and potential mechanism of gastrodia-uncaria granules based on network pharmacology and experimental validation.基于网络药理学和实验验证的天麻钩藤颗粒的降压作用及潜在机制。
J Clin Hypertens (Greenwich). 2024 Sep;26(9):1024-1038. doi: 10.1111/jch.14833. Epub 2024 Jul 11.
晚期糖基化终末产物受体在甲型流感病毒肺炎期间具有有害作用。
Virology. 2009 Sep 1;391(2):265-73. doi: 10.1016/j.virol.2009.05.032. Epub 2009 Jul 9.
4
The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.晚期糖基化终末产物受体在阿尔茨海默病中淀粉样β肽介导的病理过程中的作用。
Curr Opin Investig Drugs. 2009 Jul;10(7):672-80.
5
Soluble RAGE-modulating drugs: state-of-the-art and future perspectives for targeting vascular inflammation.可溶性 RAGE 调节药物:靶向血管炎症的最新技术和未来展望。
Curr Vasc Pharmacol. 2010 Jan;8(1):86-92. doi: 10.2174/157016110790226642.
6
RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.RAGE:炎症反应的治疗靶点和生物标志物——证据不断增加。
J Leukoc Biol. 2009 Sep;86(3):505-12. doi: 10.1189/jlb.0409230. Epub 2009 May 28.
7
Polymorphisms in glyoxalase 1 gene are not associated with vascular complications: the Hoorn and CoDAM studies.乙二醛酶1基因多态性与血管并发症无关:霍伦研究和荷兰糖尿病干预与并发症研究
J Hypertens. 2009 Jul;27(7):1399-403. doi: 10.1097/HJH.0b013e32832af6ba.
8
Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials.高血糖诱导的糖尿病并发症的治疗:从动物模型到临床试验
Nat Rev Drug Discov. 2009 May;8(5):417-29. doi: 10.1038/nrd2476.
9
Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury.晚期糖基化终末产物受体(RAGE)依赖性调节肝缺血/再灌注损伤中的早期生长反应因子-1
J Hepatol. 2009 May;50(5):929-36. doi: 10.1016/j.jhep.2008.11.022. Epub 2009 Jan 14.
10
The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia.晚期糖基化终末产物受体损害肺炎球菌肺炎中的宿主防御。
J Immunol. 2009 Apr 1;182(7):4349-56. doi: 10.4049/jimmunol.0801199.